March 26, 2010: Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud

March 26 (Bloomberg) —
Pfizer, Inc. violated U.S. racketeering law in the marketing of its epilepsy drug Neurontin and should pay $142.1 million in damages, a jury decided.

Click here to read more